Search research articles
Contact Us
Filters
Showing results (61-70 of 94) with videos related to
Page
of 10
Sort By:
Translational Lung Cancer Research
|
February 4, 2020
CT-based radiomics signature for the stratification of N2 disease risk in clinical stage I lung adenocarcinoma
Minglei Yang, Yunlang She, Jiajun Deng, et al.
The Annals of Thoracic Surgery
|
March 18, 2024
Spread Through Air Spaces in Residual Tumor Classification for Clinical IA Lung Adenocarcinoma
Haojie Si, Long Xu, Yue Zhao, et al.
Frontiers in Microbiology
|
April 9, 2026
A streamlined integrated system integrating lysate release, freeze-dried reagents for multiplex polymerase chain reaction, and intelligent analysis for TORCHes pathogen identification
Miao Fu, Siying He, Yingchao Wu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 11, 2023
Validation of the Proposed International Association for the Study of Lung Cancer Residual Tumor Classification to Upgrade Extracapsular Extension of Tumor in Nodes From R0 to Incomplete Resection
Huikang Xie, Chenyang Dai, Chang Gu, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
December 20, 2024
SNAI1 promotes epithelial-mesenchymal transition and maintains cancer stem cell-like properties in thymic epithelial tumors through the PIK3R2/p-EphA2 Axis
Haoran E, Lei Zhang, Zhenhua Yang, et al.
Iscience
|
November 8, 2022
Genopathomic profiling identifies signatures for immunotherapy response of lung adenocarcinoma via confounder-aware representation learning
Jiajun Deng, Jiancheng Yang, Likun Hou, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 25, 2021
Proposal for Rib invasion as an independent T descriptor for non-small cell lung cancer: A propensity-score matching analysis
Mengmeng Zhao, Junqi Wu, Jiajun Deng, et al.
Therapeutic Advances in Medical Oncology
|
January 16, 2023
The IASLC grading system for invasive pulmonary adenocarcinoma: a potential prognosticator for patients receiving neoadjuvant therapy
Haoran E, Junqi Wu, Yijiu Ren, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 6, 2024
Incorporation of the lepidic component as an additional pathological T descriptor for non-small cell lung cancer: Data from 3335 cases of lung adenocarcinoma
Shenghao Huang, Mengmeng Zhao, Shenghui Li, et al.
JTO Clinical and Research Reports
|
January 6, 2025
Prognostic Impact of Adjuvant Immunotherapy in Patients With Resectable NSCLC After Neoadjuvant Chemoimmunotherapy: A Brief Report
Yichen Dong, Long Xu, Jialiang Wen, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 94) with videos related to
Sort By:
Page
of 10
Translational Lung Cancer Research
|
February 4, 2020
CT-based radiomics signature for the stratification of N2 disease risk in clinical stage I lung adenocarcinoma
Minglei Yang, Yunlang She, Jiajun Deng, et al.
The Annals of Thoracic Surgery
|
March 18, 2024
Spread Through Air Spaces in Residual Tumor Classification for Clinical IA Lung Adenocarcinoma
Haojie Si, Long Xu, Yue Zhao, et al.
Frontiers in Microbiology
|
April 9, 2026
A streamlined integrated system integrating lysate release, freeze-dried reagents for multiplex polymerase chain reaction, and intelligent analysis for TORCHes pathogen identification
Miao Fu, Siying He, Yingchao Wu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 11, 2023
Validation of the Proposed International Association for the Study of Lung Cancer Residual Tumor Classification to Upgrade Extracapsular Extension of Tumor in Nodes From R0 to Incomplete Resection
Huikang Xie, Chenyang Dai, Chang Gu, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
December 20, 2024
SNAI1 promotes epithelial-mesenchymal transition and maintains cancer stem cell-like properties in thymic epithelial tumors through the PIK3R2/p-EphA2 Axis
Haoran E, Lei Zhang, Zhenhua Yang, et al.
Iscience
|
November 8, 2022
Genopathomic profiling identifies signatures for immunotherapy response of lung adenocarcinoma via confounder-aware representation learning
Jiajun Deng, Jiancheng Yang, Likun Hou, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 25, 2021
Proposal for Rib invasion as an independent T descriptor for non-small cell lung cancer: A propensity-score matching analysis
Mengmeng Zhao, Junqi Wu, Jiajun Deng, et al.
Therapeutic Advances in Medical Oncology
|
January 16, 2023
The IASLC grading system for invasive pulmonary adenocarcinoma: a potential prognosticator for patients receiving neoadjuvant therapy
Haoran E, Junqi Wu, Yijiu Ren, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 6, 2024
Incorporation of the lepidic component as an additional pathological T descriptor for non-small cell lung cancer: Data from 3335 cases of lung adenocarcinoma
Shenghao Huang, Mengmeng Zhao, Shenghui Li, et al.
JTO Clinical and Research Reports
|
January 6, 2025
Prognostic Impact of Adjuvant Immunotherapy in Patients With Resectable NSCLC After Neoadjuvant Chemoimmunotherapy: A Brief Report
Yichen Dong, Long Xu, Jialiang Wen, et al.
Page
of 10